Showing posts with label national pharmacare. Show all posts
Showing posts with label national pharmacare. Show all posts

Friday, December 1, 2023

Is It Brinkmanship?

 

H/t Moudakis

One has to wonder, given the lack of any real movement on a national pharmacare program, whether Justin Trudeau is gambling on Jagmeet Singh's NDP being more afraid of an early election than are the Liberals. Given that the polls show an almost inexplicable lead by PP's Conservatives, that is quite the roll of the dice.

For whatever reason, the NDP has never, with one real exception, captured the hearts and minds of 'ordinary Canadians'. Perhaps they consider themselves temporarily embarrassed millionaires, or fear that wild-eyed socialists will run amok in their home and native land.

However, one thing that is certain, at least in my mind, is that the Liberals, especially under their current leadership, have never met a corporate entity they didn't like. To bring in a true pharmacare program would 'disenfranchise' health insurance companies and reduce big pharma's profits by bulk purchases of drugs at significantly lower prices. Despite their rhetoric, this is not something Justin and the gang want.

All of which is to say that the rich and their money enjoy special government protection. Consider, for example, Linda McQuaig's latest column about wealth taxes and what they could achieve for an increasingly impoverished citizenry:

Understandably, people feel enraged when they can’t afford food and shelter for themselves and their children -- especially when they’re working full-time, often at several jobs. They know they’re getting the short end of the stick.

But unless they read Statistics Canada releases, they’re probably unaware just how long the other end of the stick has suddenly become.

Of course, it’s conventional wisdom that the rich always get richer.

This has not always been the case, McQuaig points out that we used to have a progressive taxation system that redistributed wealth quite effectively, but that ended in the 1980s, and now the wealthy are profiting more than they ever have.

Just-released Statistics Canada data show that, in 2021, the top 1 per cent of Canadians saw their incomes grow by fully 20 per cent. Farther up, the incomes of the top .01 per cent grew by a stunning 30 per cent -- to an average yearly income of $12.5 million. This prompted Statistics Canada, not known for rabble-rousing, to note that (in inflation-adjusted dollars) this is “much higher” than at any point in the past 40 years.

Meanwhile, that same year, the bottom half of Canadians (some 14 million working people) saw their incomes actually drop.

McQuaig's solution, which will please many and appal some, is a wealth tax. 

A wealth tax would apply exclusively to those with net assets of more than $10 million – just 87,000 families. Under one model, they’d pay 1 percent a year on assets above $10 million, 2% above $50 million and 3% above $100 million. Yet, the tax could raise an estimated $32 billion – about 60 times more than the Liberal income tax charges.

Despite almost no public debate about it, a wealth tax has the support of close to 90 per cent of Canadians.

But the current crop of politicos, both Liberal and Conservative, and their enablers, will likely continue to protect the interests of the few, since

the wealthy have managed to keep it off the agenda. Their phalanx of lawyers, accountants and economists are quick to dismiss all attempts to raise taxes on the rich. And a wealth tax, given the way it can be so effectively targeted, is considered particularly odious.

Jesus is reported to have said that the poor will always be with us. Given the sad caliber of our political overlords, I see no reason to dispute that assertion. 

 

 

Monday, April 15, 2019

Sounds Like Corporate Extortion To Me



Given all of the revelations about how the Liberals legislated Deferred Prosecutions with SNC-Lavalin expressly in mind, it is perhaps no surprise that Big Pharma is now attempting to flex its muscles to prevent legislation that would benefit all Canadians. Andy Blatchford reports the following:
Brand-name drug companies could put off introducing new medicine in Canada and scale back research here if the country makes a major shift to cheaper generic alternatives under a national pharmacare plan, according to an internal federal analysis.

The concerns were included last year in a briefing document for federal Finance Minister Bill Morneau that explored the feasibility and costs of a pharmacare program.
For those who pay obeisance to corporate power, the document was sobering:
... the briefing note to Morneau said national pharmacare could influence the revenues of drug companies in several ways. Among the possibilities, it said a shift in favour of more generic drugs, mass-produced after patent protections for new medications expire, could lower costs.

But that could come with a cost for patients.

“For example, brand-name pharmaceutical companies may respond to a broad shift to generic drugs by delaying the introduction of new drugs in the Canadian market or by reducing the R&D activities that they undertake in the country,” said the analysis, labelled “secret,” which was obtained by The Canadian Press under access-to-information law.
To use the old cliché, Big Pharma is threatening to hold Canadians hostage should legislation beneficial to them emerge:
“Innovative Medicines Canada, which represents pharmaceutical patent holders, has warned that a national pharmacare program focused on cost containment may result in reduced access to medicines for Canadians.”
Such a threat, if followed through, would be part of larger pattern of pharma's failure on behalf of Canadians.
The briefing to Morneau said research and development investments by pharma companies in Canada already “significantly lag” spending in other countries in the Organization for Economic Co-operation and Development, a group of 34 countries with advanced economies.

“Since 2003, industry investment in R&D has been less than 10 per cent of sales — the target that the pharmaceutical industry committed to in exchange for more favourable patent terms in Canada,” said the briefing to Morneau.
Like a predatory beast smelling blood, Big Pharma senses it has a Canadian government captured between its paws.

Time for us to show that we are not such easy pickings after all.